MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med The oral ...

An announcement from Jiangxi Rimag Group Co., Ltd. Class H ( ($HK:2522) ) is now available. Jiangxi Rimag Group Co., Ltd. has announced the ...

Read to the bottom for our calendar of key events—and one more thing.

In continuation to our letter dated May 28, 2025, informing the Dispatch of Postal Ballot for seeking Shareholders approval ...

Biometric logins, such as facial recognition, are becoming increasingly common within mobile banking apps to ensure they are ...